Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
23 06 2019
Historique:
entrez: 9 7 2019
pubmed: 10 7 2019
medline: 9 6 2020
Statut: epublish

Résumé

Bronchoscopy is a medical procedure whereby normal saline is injected into the lungs via a bronchoscope and then suction is applied, removing bronchoalveolar lavage (BAL) fluid. The BAL fluid is rich in cells and can thus provide a 'snapshot' of the pulmonary immune milieu. CD4 T cells are the best characterized HIV reservoirs, while there is strong evidence to suggest that tissue macrophages, including alveolar macrophages (AMs), also serve as viral reservoirs. However, much is still unknown about the role of AMs in the context of HIV reservoir establishment and maintenance. Therefore, developing a protocol for processing BAL fluid to obtain cells that may be used in virological and immunological assays to characterize and evaluate the cell populations and subsets within the lung is relevant for understanding the role of the lungs as HIV reservoirs. Herein, we describe such a protocol, employing standard techniques such as simple centrifugation and flow cytometry. The CD4 T cells and AMs may then be used for subsequent applications, including immunophenotyping and HIV DNA and RNA quantification.

Identifiants

pubmed: 31282892
doi: 10.3791/59427
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : 153082
Pays : Canada
Organisme : CIHR
ID : HB2-164064
Pays : Canada

Auteurs

Syim Salahuddin (S)

Research Institute McGill University Health Centre; Department of Biological Sciences, Université de Québec à Montréal.

Elaine Thomson (E)

Research Institute McGill University Health Centre; Department of Biological Sciences, Université de Québec à Montréal; Department of Microbiology & Immunology, McGill University.

Oussama Méziane (O)

Research Institute McGill University Health Centre; Department of Biological Sciences, Université de Québec à Montréal.

Omar Farnos (O)

Department of Biological Sciences, Université de Québec à Montréal.

Amélie Pagliuzza (A)

Centre de Recherche du Centre Hospitalier de l'Université de Montréal.

Nicolas Chomont (N)

Centre de Recherche du Centre Hospitalier de l'Université de Montréal; Département de microbiologie, infectiologie et immunologie, Université de Montréal.

Ron Olivenstein (R)

Research Institute McGill University Health Centre.

Cecilia Costiniuk (C)

Research Institute McGill University Health Centre; Department of Microbiology & Immunology, McGill University; Department of Medicine, Division of Infectious Diseases, McGill University.

Mohammad-Ali Jenabian (MA)

Department of Biological Sciences, Université de Québec à Montréal; Department of Microbiology & Immunology, McGill University; Département de microbiologie, infectiologie et immunologie, Université de Montréal; jenabian.mohammad-ali@uqam.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH